Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
5,001	43.23599	1	male	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$25-$50k	0	null	36,952.3438	34,295	46	black	32.59375	53	0.754883	0.67688	1	0	0	no	0.7	0.7	no dnr	11	110	30.398438	80	27	38.69531	56.66406	2.899902	0.899902	2.299805	126	7.5	340	39	740	null	0	<2 mo. follow-up	0
5,002	67.93195	1	female	0	7	565	CHF	COPD/CHF/Cirrhosis	2	14	null	0	null	4,060.2891	3,705	4	white	13.699219	28	0.908936	0.8479	1	0	0	no	0.9	0.85	no dnr	7	75	15.798828	110	30	36.19531	264	2.5	0.399963	0.899902	135	7.419922	198	14	1,300	3	3	no(M2 and SIP pres)	3
5,003	65.008	1	male	0	7	315	CHF	COPD/CHF/Cirrhosis	3	null	null	0	null	4,747.207	4,657	6.5	white	14.5	14	0.908936	0.846924	1	1	0	no	null	null	no dnr	7	100	14.699219	100	22	36.39844	null	null	0.699951	1.5	125	null	158	16	3,205	null	null	null	2.532227
5,004	73.62097	0	male	0	13	716	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	0	25,411	15,708.2734	15,444	15.5	black	24.097656	45	0.774902	0.701904	1	0	0	no	0.75	0.7	no dnr	13	80	4.799805	75	20	39.19531	null	2.799805	0.599976	1.099854	134	null	111	9	1,300	1	0	no(M2 and SIP pres)	0
5,005	67.49097	0	male	0	28	716	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	under $11k	0	98,625	55,380.875	55,038	21.25	white	29.796875	40	0.697998	0.606934	1	0	0	no	0.3	0.25	no dnr	28	62	7.699219	110	31	36.89844	276.625	null	1.099854	3.099609	143	7.369141	99	59	2,050	null	0	adl>=4 (>=5 if sur)	0
5,006	70.21198	0	male	0	48	716	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	55	102,847	null	null	27.25	white	33.195313	39	0.332947	0.217987	1	0	0	no	null	null	no dnr	48	75	9.398438	64	20	37.5	null	null	0.399963	1.099854	132	null	163	9	null	null	0	adl>=4 (>=5 if sur)	0
5,007	74.40094	1	female	0	79	80	COPD	COPD/CHF/Cirrhosis	2	8	null	0	299,345	172,386.5	169,766	41.25	white	38.09375	39	0.302979	0.123993	13	1	0	no	0.75	0.95	dnr after sadm	17	142	28.398438	115	28	36.69531	122.4375	2	0.399963	9.798828	135	7.399414	133	87	97	null	3	SIP>=30	3
5,008	65.42896	0	female	0	41	713	ARF/MOSF w/Sepsis	ARF/MOSF	0	11	under $11k	9	103,987	62,892.3125	60,438	28.75	black	31.796875	47	0.567993	0.45697	5	0	0	no	null	null	no dnr	41	58	12.099609	95	14	37.69531	410	null	null	1.099854	132	7.469727	137	24	1,270	null	0	no(M2 and SIP pres)	0
5,009	38.13599	1	female	0	12	46	MOSF w/Malig	ARF/MOSF	3	12	$25-$50k	0	35,399	21,580.125	21,693	27.5	white	34.59375	52	0.319946	0.205994	5	0	0	metastatic	0.7	0.3	dnr after sadm	6	67	12.199219	76	24	38.19531	600	2.799805	null	0.799927	131	7.469727	51	3	2,525	1	0	<2 mo. follow-up	0
5,010	73.32196	1	male	0	4	380	Lung Cancer	Cancer	1	16	null	0	null	2,548.1387	3,293	15	white	16.296875	18	0.701904	0.415955	1	0	0	metastatic	null	null	no dnr	4	52	10.798828	45	24	36.5	222.84375	2.399902	2.799805	5	130	7.269531	268	89	3,200	0	null	no(M2 and SIP pres)	0.494751
5,011	64.45197	1	male	0	8	165	Colon Cancer	Cancer	1	null	null	0	14,340	8,680.0156	7,993	10.5	white	15.398438	10	0.837891	0.645996	1	0	0	metastatic	null	null	no dnr	8	50	13.5	125	35	36.59375	120	null	null	2.599609	127	7.349609	280	48	1,023	null	null	null	2.215332
5,012	67.49896	0	female	0	24	711	COPD	COPD/CHF/Cirrhosis	1	11	$11-$25k	0	37,117	23,135.1562	24,473	18	white	24.898438	24	0.763916	0.625	3	0	0	no	null	null	no dnr	24	125	16.898438	115	40	38.09375	226	null	null	2.799805	145	7.469727	133	79	1,540	0	0	no(M2 and SIP pres)	0
5,013	62.20898	1	male	0	9	601	COPD	COPD/CHF/Cirrhosis	2	11	under $11k	0	37,356	23,096.7031	22,627	18	white	20.097656	20	0.853882	0.758911	4	0	0	no	0.98	0.95	no dnr	9	68	10.599609	115	35	37.89844	157.125	2.799805	1.199951	2.299805	134	7.239258	306	35	2,394	0	0	no(M2 and SIP pres)	0
5,014	63.95297	0	male	0	15	710	CHF	COPD/CHF/Cirrhosis	4	15	>$50k	0	46,614	null	null	21.333328	white	29.597656	43	0.727905	0.574951	1	1	0	no	0.8	0.75	no dnr	15	71	19.597656	60	16	35.5	null	2.299805	0.399963	0.699951	137	null	78	6	2,800	null	1	no(M2 and SIP pres)	1
5,015	53.81799	1	male	0	44	431	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	87,681	51,575.9688	56,810	19.25	white	19.097656	18	0.861938	0.814941	1	0	0	yes	0.9	0.8	no dnr	44	72	11.298828	50	10	35.89844	144	null	0.599976	2.399902	133	7.529297	158	88	1,620	0	0	no(M2 and SIP pres)	0
5,016	72.72797	1	male	0	20	259	CHF	COPD/CHF/Cirrhosis	2	8	null	0	35,733	21,160.5781	21,977	27	white	48	63	0.178986	0.049995	1	0	0	no	0.9	0.7	no dnr	20	70	4.699219	75	16	35.59375	null	null	1.199951	1.299805	142	null	140	41	1,880	null	1	null	1
5,017	76.36694	1	male	0	21	38	Colon Cancer	Cancer	1	14	null	0	23,314	15,320.5312	13,569	10.333328	white	28.699219	14	0.553955	0.230988	1	0	0	metastatic	0.7	0.5	no dnr	21	112	7.199219	130	16	36	213.3125	2.899902	0.5	0.799927	139	7.40918	165	12	980	null	1	<2 mo. follow-up	1
5,018	66.27795	1	male	0	13	128	ARF/MOSF w/Sepsis	ARF/MOSF	2	0	under $11k	9	87,124	49,238.125	51,733	16.5	other	28.296875	45	0.61792	0.512939	13	1	0	no	null	null	no dnr	13	48	9.099609	115	24	35.79688	363.3125	2.199707	3	5.699219	143	7.429688	137	51	23	null	2	adl>=4 (>=5 if sur)	2
5,019	82.70996	1	female	0	20	30	ARF/MOSF w/Sepsis	ARF/MOSF	2	14	>$50k	0	81,507	50,401.25	48,716	34.333313	white	28.5	40	0.493958	0.376953	1	0	0	metastatic	0.2	0.1	no dnr	20	160	19	55	16	38.19531	210	null	null	1.099854	142	7.489258	185	14	3,480	null	7	<2 mo. follow-up	7
5,020	63.76999	1	male	0	7	150	Lung Cancer	Cancer	1	null	null	0	10,343	6,567.582	6,025	9.5	white	24.597656	14	0.532959	0.209991	1	0	0	metastatic	0.5	0.1	no dnr	7	85	6.299805	75	20	36.19531	null	2.399902	0.799927	1.299805	140	null	72	29	null	null	null	null	3.005371
5,021	51.58698	0	male	0	41	707	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	9	80,835	52,924.9062	52,753	19.75	black	31.296875	75	0.691895	0.599976	2	1	0	no	0.7	0.7	no dnr	41	118	4.799805	125	10	36.19531	260	4	0.699951	0.799927	137	7.40918	121	11	3,730	null	1	SIP>=30	1
5,022	75.82495	1	female	0	10	14	MOSF w/Malig	ARF/MOSF	2	null	under $11k	0	33,451	20,574.2031	20,619	23.5	black	24.097656	26	0.517944	0.401978	11	1	0	metastatic	0.1	0.1	dnr after sadm	6	118	0.099991	135	25	38.19531	200	2.099609	0.699951	3	133	7.359375	248	124	1,805	null	6	<2 mo. follow-up	6
5,023	69.66498	1	male	1	19	19	Coma	Coma	0	0	null	37	70,791	42,966.5312	41,661	25.666656	black	29.796875	62	0.311951	0.240997	1	0	0	no	0.6	0.6	dnr after sadm	18	108	14.798828	70	18	36.79688	308	null	0.599976	0.899902	137	7.469727	280	27	null	null	0	<2 mo. follow-up	0
5,024	82.69995	1	male	1	30	30	ARF/MOSF w/Sepsis	ARF/MOSF	2	9	$11-$25k	9	44,008	28,144.6562	28,474	13.5	white	19.398438	40	0.748901	0.669922	5	0	0	no	null	null	dnr after sadm	3	110	8.099609	100	22	36.29688	347.5625	null	0.399963	0.899902	135	7.469727	92	6	null	null	6	<2 mo. follow-up	6
5,025	58.19299	1	male	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	0	25,996	15,017.2188	15,660	14	white	31.199219	30	0.504883	0.387939	6	0	0	metastatic	0.4	0.1	dnr after sadm	5	73	6.899414	120	27	38.59375	161.65625	null	0.699951	1.699951	136	7.5	172	30	3,165	null	null	<2 mo. follow-up	2.782715
5,026	33.78	0	female	0	15	705	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	0	41,677	25,193.125	23,917	28	white	29.796875	42	0.828979	0.770996	1	0	0	no	0.8	0.8	no dnr	15	58	3.399902	110	10	36.09375	126	null	2.5	0.799927	146	7.469727	217	25	3,120	null	null	no(M2 and SIP pres)	2.071777
5,027	47.93198	0	female	0	22	705	ARF/MOSF w/Sepsis	ARF/MOSF	1	13	null	0	58,215	null	null	23	black	23.597656	39	0.832886	0.776978	5	1	0	no	0.9	0.9	no dnr	22	75	17.898438	115	10	36.09375	148.875	2.199707	null	0.699951	136	7.509766	157	36	3,065	0	null	null	0.494751
5,028	48.375	1	male	0	8	50	MOSF w/Malig	ARF/MOSF	2	9	under $11k	9	19,396	11,940.75	11,809	21	white	21.296875	22	0.681885	0.588989	1	0	0	metastatic	0.25	0.05	dnr after sadm	5	78	5	65	16	36.39844	214.28125	null	0.5	1.799805	136	7.439453	178	48	2,050	null	0	<2 mo. follow-up	0
5,029	65.37396	1	female	1	61	61	COPD	COPD/CHF/Cirrhosis	1	12	>$50k	0	413,887	246,825.125	253,225	29	white	26	43	0.698975	0.534912	105	0	0	no	0.4	0.4	dnr after sadm	59	132	11.898438	55	10	34.19531	270	1.599854	1.199951	1.299805	136	7.289062	240	17	null	null	2	null	2
5,030	64.53699	0	male	0	9	703	COPD	COPD/CHF/Cirrhosis	1	7	$25-$50k	0	11,580	7,392.9297	7,688	12.5	white	21.597656	39	0.848999	0.751953	1	0	0	no	1	1	no dnr	9	97	7.899414	80	28	36.79688	247.59375	null	null	0.5	139	7.479492	185	11	900	0	0	no(M2 and SIP pres)	0
5,031	57.46198	0	male	0	27	703	COPD	COPD/CHF/Cirrhosis	3	18	$25-$50k	0	21,367	15,081.9297	19,774	7.25	white	14.298828	13	0.931885	0.883911	1	1	0	no	null	null	dnr after sadm	1	86	11.599609	88	22	37	256	3.399902	0.5	1.299805	143	7.369141	147	22	2,000	6	null	no(M2 and SIP pres)	4.527344
5,032	47.69598	1	male	1	5	5	MOSF w/Malig	ARF/MOSF	1	12	$25-$50k	0	32,557	18,351.9062	17,679	52	black	45.796875	75	0.144989	0.068985	1	0	0	yes	0.4	0.35	dnr after sadm	5	142	0.199982	115	25	39.39844	120	2.299805	1.399902	0.599976	129	7.439453	201	13	5,630	null	2	<2 mo. follow-up	2
5,033	56.60199	1	female	1	7	7	Cirrhosis	COPD/CHF/Cirrhosis	3	null	null	26	18,544	11,228.7109	10,687	9.5	black	34.796875	38	0.329956	0.144989	2	0	0	no	0.5	0.4	dnr after sadm	7	122	9.699219	115	12	38.19531	187.5	2.899902	2.799805	1.199951	137	7.459961	83	16	4,150	null	0	<2 mo. follow-up	0
5,034	66.41998	0	male	0	68	702	ARF/MOSF w/Sepsis	ARF/MOSF	2	9	under $11k	0	236,103	136,933.75	146,712	40.25	white	27.898438	53	0.689941	0.5979	5	1	0	no	0.8	0.8	no dnr	68	65	7.799805	65	33	37.69531	232.5	null	null	0.899902	138	7.509766	110	20	850	null	0	no(M2 and SIP pres)	0
5,035	23.55099	0	female	0	104	702	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$25-$50k	0	433,851	245,377.875	254,332	39.25	white	32.898438	43	0.779907	0.708984	6	1	0	no	0.6	0.6	no dnr	104	122	17.898438	115	31	36.5	208.5625	3.299805	null	1.099854	133	7.489258	248	23	2,230	null	5	adl>=4 (>=5 if sur)	5
5,036	57.74698	1	female	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	0	10	$11-$25k	0	89,650	50,894.0938	50,447	43.5	white	32.796875	36	0.587891	0.478943	18	0	0	no	0.5	0.5	dnr after sadm	7	107	13.898438	135	39	37.69531	246.65625	null	8	2.099609	150	7.439453	115	31	3,610	null	0	<2 mo. follow-up	0
5,037	62.508	1	male	1	10	10	ARF/MOSF w/Sepsis	ARF/MOSF	0	17	null	0	58,969	34,627.7812	37,208	42.5	white	32	53	0.655884	0.556885	2	0	0	no	0.6	0.4	dnr after sadm	10	72	3.599609	79	32	36.79688	265	2.199707	null	0.899902	140	7.279297	69	14	2,950	null	0	<2 mo. follow-up	0
5,038	76.97998	1	male	1	35	35	ARF/MOSF w/Sepsis	ARF/MOSF	1	21	>$50k	0	236,578	131,075.25	116,139	46.75	white	42	65	0.130981	0.059998	14	0	0	yes	null	null	dnr after sadm	16	127	7	105	0	38.39844	188.875	null	null	1.699951	142	7.449219	183	38	2,550	null	5	<2 mo. follow-up	5
5,039	79.59796	0	male	0	12	700	ARF/MOSF w/Sepsis	ARF/MOSF	2	5	under $11k	9	25,694	18,034.7812	17,946	17	black	26	49	0.68396	0.590942	1	1	0	no	0.7	0.6	no dnr	12	115	7	130	16	37.89844	316	null	null	0.799927	139	7.459961	136	10	2,350	null	0	no(M2 and SIP pres)	0
5,040	75.63599	0	female	0	61	699	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	null	37	140,074	87,156.75	86,931	34	white	27.199219	49	0.560913	0.448975	1	0	0	no	0.6	0.55	dnr after sadm	31	53	10.898438	105	12	37	162.5	null	null	1.299805	125	7.459961	96	25	1,650	null	0	SIP>=30	0
5,041	62.84998	1	male	1	4	4	CHF	COPD/CHF/Cirrhosis	6	16	$25-$50k	100	9,831	6,922.8008	6,586	35	black	99.1875	108	0	0	1	1	0	no	null	null	no dnr	4	105	22.097656	65	20	36	376	3.599609	0.699951	2.099609	136	7.439453	161	57	2,050	null	0	<2 mo. follow-up	0
5,042	75.65198	1	female	1	7	7	Colon Cancer	Cancer	1	null	null	26	7,277	4,784.5391	4,951	8.5	white	25.898438	41	0.507935	0.186981	1	0	0	metastatic	0.2	0.1	dnr after sadm	1	72	15.898438	55	14	36.19531	219.03125	null	0.699951	0.699951	138	7.399414	126	14	2,580	null	4	<2 mo. follow-up	4
5,043	44.97498	1	female	0	4	245	Colon Cancer	Cancer	1	12	$25-$50k	0	6,834	4,132.0703	3,226	1	white	14.699219	9	0.873901	0.716919	1	0	0	metastatic	0.85	0.6	no dnr	4	146	17.898438	120	10	38.5	98.5625	null	null	0.799927	153	7.449219	105	26	3,635	null	null	no(M2 and SIP pres)	2.183594
5,044	70.71899	1	male	0	4	301	Lung Cancer	Cancer	1	13	under $11k	0	3,052	null	null	7	white	12.398438	2	0.777954	0.535889	1	0	0	metastatic	0.65	0.25	no dnr	4	80	9.199219	75	20	35.19531	330	null	null	1.799805	140	7.589844	75	41	925	null	0	no(M2 and SIP pres)	0
5,045	64.55896	0	male	0	13	696	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	0	53,126	30,766.7812	34,528	41.5	other	24.597656	21	0.775879	0.702881	3	1	0	no	0.7	0.6	no dnr	13	67	12.398438	120	22	38	null	null	null	0.699951	131	null	149	5	1,750	null	3	no(M2 and SIP pres)	3
5,046	69.36597	1	male	0	19	469	ARF/MOSF w/Sepsis	ARF/MOSF	2	0	under $11k	0	41,611	23,837.875	24,459	19.666656	white	23.296875	40	0.777954	0.705933	3	0	0	no	0.4	0.3	dnr before sadm	-2	112	15.599609	125	14	38.79688	137.5	2.399902	0.799927	0.599976	136	7.449219	113	20	2,555	null	null	SIP>=30	2.86084
5,047	75.23895	1	male	0	6	58	CHF	COPD/CHF/Cirrhosis	2	13	$25-$50k	0	5,511	4,134.3594	3,908	12	white	16.199219	32	0.871948	0.786987	1	0	0	no	null	null	no dnr	6	105	14.5	95	12	38.5	246.65625	3.399902	7	0.899902	135	7.439453	107	11	3,170	0	null	<2 mo. follow-up	0.494751
5,048	68.62695	1	male	0	54	117	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	under $11k	9	135,769	null	null	32.5	black	20.398438	13	0.787964	0.718994	5	1	0	no	0.75	0.5	dnr after sadm	1	70	13.298828	120	32	39.29688	151.65625	null	null	2.899902	142	7.419922	115	42	1,960	null	null	adl>=4 (>=5 if sur)	2.023438
5,049	44.172	1	male	0	21	24	Lung Cancer	Cancer	4	12	null	0	19,222	12,926.8438	13,219	7.333332	black	23	34	0.630981	0.31897	1	0	0	metastatic	0.2	0.05	dnr after sadm	2	67	5.399414	82	16	36	357.125	4.199219	2.199707	0.899902	133	7.479492	105	23	2,400	0	null	<2 mo. follow-up	0.494751
5,050	39.81699	1	male	0	20	64	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	41	55,934	34,209.9375	32,849	28.666656	black	32.398438	64	0.626953	0.523926	1	0	0	no	0.3	0.15	no dnr	20	110	8.199219	80	20	37	404.75	3.299805	1.199951	1.099854	139	7.469727	81	21	2,300	null	null	null	2.771973
5,051	80.35895	1	male	0	19	28	Lung Cancer	Cancer	1	6	under $11k	26	16,602	11,312.6719	14,701	9.333328	black	24.296875	29	0.350952	0.074997	1	0	0	metastatic	0.3	0.5	dnr after sadm	3	130	35.398438	125	28	36.29688	356	4	null	0.899902	139	7.369141	110	22	620	null	2	<2 mo. follow-up	2
5,052	61.92999	1	male	1	20	20	ARF/MOSF w/Sepsis	ARF/MOSF	3	13	under $11k	61	139,557	79,442	81,775	37.333313	white	22	61	0.571899	0.460999	12	1	0	no	0.4	0.15	dnr after sadm	7	78	15.798828	105	11	36.79688	170	null	2.099609	3.099609	137	7.40918	100	58	3,470	null	0	<2 mo. follow-up	0
5,053	71.35895	0	male	0	10	691	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	9	55,359	32,655.5	34,134	21	white	25.898438	26	0.646973	0.546997	12	0	0	no	0.95	0.93	no dnr	10	60	14.398438	135	24	38.09375	112.23438	null	0.5	0.799927	125	7.549805	193	28	1,050	null	null	null	2.520508
5,054	74.37396	1	female	1	18	18	COPD	COPD/CHF/Cirrhosis	2	null	under $11k	0	24,211	null	null	13	white	23.5	31	0.765991	0.62793	1	1	0	no	0.6	0.4	dnr after sadm	8	138	17.398438	0	38	38	260.8125	3	1.199951	0.5	143	7.239258	268	14	2,797	null	2	<2 mo. follow-up	2
5,055	50.14398	0	male	0	13	691	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	37,721	22,164.2344	21,922	26.5	white	22.097656	30	0.861938	0.813965	2	1	0	no	0.5	0.45	no dnr	13	60	6.099609	125	13	38.79688	158	null	5.299805	1.399902	149	7.379883	283	16	3,430	1	0	SIP>=30	0
5,056	69.67798	1	male	0	28	77	ARF/MOSF w/Sepsis	ARF/MOSF	2	14	$11-$25k	100	42,808	26,644.5	26,009	13	white	23.296875	47	0.305969	0.19397	1	0	0	yes	0.7	0.6	dnr after sadm	7	113	3.5	125	35	36.19531	185.6875	null	1.799805	2.199707	140	7.389648	149	33	1,225	null	7	adl>=4 (>=5 if sur)	7
5,057	76.62695	0	male	0	7	691	Colon Cancer	Cancer	1	19	null	0	13,251	7,951.0664	7,827	7.5	white	22.398438	16	0.700928	0.414978	1	0	0	metastatic	0.85	0.6	no dnr	7	63	4.699219	79	28	38	null	3.299805	null	1	135	null	88	9	null	null	null	no(M2 and SIP pres)	1.975342
5,058	24.02199	1	female	1	18	18	Cirrhosis	COPD/CHF/Cirrhosis	2	12	null	44	101,207	null	null	42.666657	black	39.296875	61	0.459961	0.258972	2	0	0	no	0.15	0.05	dnr after sadm	16	100	null	65	20	36.09375	null	null	0.699951	1	139	null	88	6	1,590	null	0	<2 mo. follow-up	0
5,059	37.34198	1	male	1	9	9	ARF/MOSF w/Sepsis	ARF/MOSF	4	10	under $11k	44	34,273	19,557.6719	17,295	41.5	black	48.898438	100	0.167999	0.084991	1	0	0	no	0.25	0.1	dnr after sadm	8	115	14.898438	105	24	35.59375	284	3.199707	0.5	0.699951	149	7.449219	125	21	655	null	0	<2 mo. follow-up	0
5,060	76.23798	1	male	1	27	27	COPD	COPD/CHF/Cirrhosis	6	3	null	0	69,596	42,462.75	45,356	21	white	23.898438	38	0.669922	0.497986	13	1	0	no	0.5	0.5	dnr after sadm	11	98	10.398438	95	24	36.89844	223.3125	3.099609	1.299805	1.5	139	7.359375	94	31	2,760	null	6	<2 mo. follow-up	6
5,061	73.36597	0	male	0	8	690	COPD	COPD/CHF/Cirrhosis	2	14	under $11k	0	7,477	5,118.168	5,491	12.5	black	19.699219	24	0.826904	0.717896	1	0	0	no	0.9	0.9	no dnr	8	118	10.798828	145	10	38.09375	205.6875	null	0.599976	2.199707	126	7.389648	199	62	3,510	null	1	no(M2 and SIP pres)	1
5,062	66.75696	1	male	0	4	52	Lung Cancer	Cancer	2	14	$25-$50k	0	4,269	2,855.1348	2,803	9	black	14.898438	14	0.743896	0.480957	1	1	0	metastatic	0.6	0.2	no dnr	4	107	79.390625	88	20	37.69531	205.6875	3.299805	0.799927	1.699951	140	7.429688	97	13	3,370	null	null	<2 mo. follow-up	2.84668
5,063	62.15698	0	female	0	28	690	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	null	0	77,908	45,678.2188	43,515	25.5	white	23.398438	32	0.755981	0.677979	3	0	0	yes	0.7	0.65	no dnr	28	43	27.199219	0	12	38	164	3.699707	1	1.899902	126	7.319336	297	30	1,650	null	0	no(M2 and SIP pres)	0
5,064	81.57697	1	male	1	20	20	Lung Cancer	Cancer	1	16	$25-$50k	0	25,226	15,696.3906	16,137	9.666664	white	16.796875	26	0.670898	0.371948	1	0	0	metastatic	0.5	0.3	dnr after sadm	11	117	12.298828	97	20	35.29688	null	2.799805	1.5	1	136	null	98	18	1,600	null	0	<2 mo. follow-up	0
5,065	76.271	0	male	0	14	688	COPD	COPD/CHF/Cirrhosis	1	13	under $11k	9	37,912	21,666.0156	22,946	20.333328	white	25.5	24	0.681885	0.512939	1	0	0	no	0.6	0.6	no dnr	14	65	10.099609	65	24	34.69531	388	null	null	1.899902	127	7.459961	211	50	930	0	3	no(M2 and SIP pres)	3
5,066	45.17697	0	male	0	16	686	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	under $11k	0	61,094	null	null	16.666656	black	22.5	42	0.850952	0.79895	6	0	0	no	0.9	0.9	no dnr	16	59	10.398438	130	12	36.59375	160	2.099609	null	0.399963	137	7.40918	134	13	1,585	0	0	no(M2 and SIP pres)	0
5,067	81.74695	1	female	0	18	311	COPD	COPD/CHF/Cirrhosis	2	14	null	9	20,315	13,006.9844	14,392	12.666664	white	26.097656	22	0.61499	0.427979	1	0	0	no	null	null	dnr after sadm	2	113	10.798828	117	24	36.29688	null	3.099609	0.399963	1.099854	136	null	113	15	null	0	1	adl>=4 (>=5 if sur)	1
5,068	68.70099	1	male	0	5	161	Lung Cancer	Cancer	1	11	$25-$50k	0	8,034	4,381.0547	2,749	10	white	25.597656	22	0.487976	0.168976	1	0	0	metastatic	0.8	0.3	no dnr	5	127	21.199219	65	27	34.5	155	2.799805	null	12.298828	132	7.289062	318	97	0	0	0	no(M2 and SIP pres)	0
5,069	40.323	0	male	0	6	685	Cirrhosis	COPD/CHF/Cirrhosis	3	12	under $11k	0	6,150	null	null	9	white	13.099609	23	0.928955	0.878906	1	0	0	no	0.99	0.95	no dnr	6	115	18.5	110	27	36.19531	192.5	2.199707	0.5	1.299805	142	7.399414	89	15	3,545	0	1	no(M2 and SIP pres)	1
5,070	54.87997	1	male	1	8	8	CHF	COPD/CHF/Cirrhosis	4	10	under $11k	0	9,508	6,299.5547	6,980	13	black	26.398438	42	0.817993	0.704956	1	1	0	no	0.4	0.25	dnr after sadm	2	120	19.5	155	40	35.39844	300	2.5	1.599854	1.599854	135	7.439453	244	43	1,875	null	5	<2 mo. follow-up	5
5,071	67.85999	1	male	0	35	54	COPD	COPD/CHF/Cirrhosis	1	12	under $11k	0	41,179	26,610.875	28,870	13.25	white	23.097656	41	0.813965	0.697998	1	0	0	no	0.6	0.5	dnr after sadm	23	73	9.898438	70	28	36	260	null	null	1.5	137	7.389648	88	53	1,100	null	6	<2 mo. follow-up	6
5,072	62.73499	0	male	0	10	684	Colon Cancer	Cancer	1	12	$11-$25k	0	24,370	14,301.3906	13,667	23.5	white	29.5	36	0.580933	0.260986	1	0	0	metastatic	0.85	0.6	no dnr	10	113	30.898438	110	22	35.5	175	3.099609	0.799927	0.5	130	7.429688	223	14	1,510	0	0	no(M2 and SIP pres)	0
5,073	33.59299	0	female	0	35	683	Coma	Coma	0	14	$11-$25k	89	141,781	79,643	77,889	43.5	black	25.699219	29	0.472961	0.399963	4	0	0	no	0.8	0.75	no dnr	35	105	3.399902	110	33	35.19531	192.5	2.199707	1.099854	0.899902	144	7.419922	535	12	1,840	null	0	adl>=4 (>=5 if sur)	0
5,074	67.849	0	male	0	18	683	Colon Cancer	Cancer	3	13	$11-$25k	0	42,241	25,081.6094	24,191	20.333328	white	13.5	16	0.853882	0.67688	1	0	0	metastatic	null	null	no dnr	18	75	19.597656	125	28	37.69531	360	1.599854	1	1.699951	143	7.399414	62	18	2,940	0	0	no(M2 and SIP pres)	0
5,075	75.98395	1	male	1	14	14	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	under $11k	9	124,688	69,735.1875	66,838	36	white	32.195313	57	0.454956	0.335999	11	0	0	no	0.5	0.5	dnr after sadm	14	128	7	115	10	38	266.625	2.5	0.5	0.599976	130	7.379883	125	8	1,570	null	0	<2 mo. follow-up	0
5,076	59.98898	1	male	1	4	4	Coma	Coma	0	null	null	100	19,554	11,011.9375	10,200	32	white	47.695313	79	0	0	1	0	0	no	null	null	dnr after sadm	3	148	13.099609	125	40	36.29688	240	null	0.5	0.5	140	7.399414	166	36	1,920	null	null	<2 mo. follow-up	2.384766
5,077	66.16296	1	female	0	5	23	Lung Cancer	Cancer	1	12	$25-$50k	0	3,425	2,377.1035	2,767	8	white	32	21	0.30896	0.053993	1	0	0	metastatic	null	null	no dnr	5	100	8.199219	112	24	36.29688	191.28125	null	null	1.299805	136	7.349609	78	24	1,850	1	null	<2 mo. follow-up	1.166748
5,078	54.34598	1	male	1	4	4	MOSF w/Malig	ARF/MOSF	1	12	under $11k	0	39,155	22,249.7188	23,339	41	white	46.796875	85	0.060997	0.021	8	0	0	yes	0.01	0.01	dnr after sadm	1	120	5.399414	84	24	36.59375	216	null	null	1	139	7.429688	95	10	null	null	null	<2 mo. follow-up	1.947022
5,079	51.129	0	male	0	29	680	ARF/MOSF w/Sepsis	ARF/MOSF	0	11	under $11k	0	131,464	74,448	71,239	37	hispanic	35.398438	72	0.612915	0.506958	4	0	0	no	0.5	0.5	no dnr	29	50	7.5	140	20	41.19531	62	2.799805	1.099854	4.599609	149	7.419922	269	73	1,320	null	null	null	2.016113
5,080	71.69897	1	male	1	13	13	ARF/MOSF w/Sepsis	ARF/MOSF	3	6	under $11k	0	107,816	61,209.9062	60,001	35	white	32.796875	50	0.427979	0.307983	11	0	0	yes	null	null	dnr after sadm	11	72	22.199219	105	24	35	300	null	21.898438	1.699951	142	7.399414	109	15	null	null	3	<2 mo. follow-up	3
5,081	38.905	0	female	0	15	679	ARF/MOSF w/Sepsis	ARF/MOSF	0	15	$25-$50k	0	98,683	53,027.2812	63,449	13.666664	white	26.796875	55	0.809937	0.745972	8	0	0	no	null	null	no dnr	15	103	12	145	42	39	236.65625	null	null	1.399902	160	7.459961	378	36	1,955	0	0	no(M2 and SIP pres)	0
5,082	71.43896	1	female	0	12	47	Lung Cancer	Cancer	1	4	$11-$25k	0	12,884	8,372.8438	8,295	6.5	white	25.597656	16	0.478943	0.161987	1	0	0	metastatic	0.3	0.1	no dnr	12	68	16.398438	135	36	39.59375	122.21875	3.099609	1	0.599976	134	7.509766	78	21	2,210	4	5	<2 mo. follow-up	5
5,083	71.625	1	female	1	24	24	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	126,801	70,188.5625	76,054	42	white	21.796875	72	0.770996	0.697998	7	0	0	no	0.3	0.15	dnr after sadm	16	63	45.5	115	22	37.79688	100	2.5	4.399414	0.799927	151	7.339844	62	9	4,270	null	6	<2 mo. follow-up	6
5,084	55.79999	1	female	0	12	63	Lung Cancer	Cancer	1	15	null	0	11,030	7,579.8672	8,021	8	white	15.5	13	0.755981	0.500977	1	0	0	metastatic	0.7	0.3	no dnr	12	103	1.099854	75	29	36.5	196.65625	2.5	5.199219	1.799805	142	7.489258	174	41	1,070	1	2	null	2
5,085	33.405	1	male	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	26	198,996	130,510.75	157,130	55	white	59.695313	114	0.016998	0.004	10	0	0	no	null	null	dnr after sadm	4	53	23.097656	120	12	39.29688	138.4375	3.399902	5	3.899902	146	7.479492	88	79	1,545	null	null	<2 mo. follow-up	1.804443
5,086	43.25	1	male	1	14	14	ARF/MOSF w/Sepsis	ARF/MOSF	0	8	under $11k	0	133,810	72,628.0625	63,859	53.333313	white	28.699219	66	0.800903	0.734985	2	0	0	no	0.5	0.5	dnr after sadm	12	133	8.5	115	33	39.39844	259.25	3.199707	1.599854	2.899902	145	7.479492	212	81	2,215	null	5	<2 mo. follow-up	5
5,087	38.68298	0	female	0	6	676	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	17,416	11,765.0156	12,120	20	black	20	16	0.910889	0.878906	1	1	0	no	0.8	0.8	no dnr	6	132	13.199219	140	26	38.29688	131.09375	null	0.699951	0.899902	143	7.459961	331	28	4,210	0	1	no(M2 and SIP pres)	1
5,088	48.04099	1	male	0	7	253	ARF/MOSF w/Sepsis	ARF/MOSF	2	13	null	0	21,921	12,741.7891	12,294	21.5	white	18.597656	23	0.897949	0.861938	2	0	0	no	0.8	0.75	no dnr	7	0	11.798828	0	0	36.39844	31	1	0.799927	2	136	7.239258	267	48	1,415	0	0	no(M2 and SIP pres)	0
5,089	69.64294	0	female	0	15	674	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	0	58,826	32,107.7812	37,998	20	white	21.5	39	0.803955	0.738892	3	1	1	no	0.95	0.93	no dnr	15	53	9.599609	96	20	34.29688	340	null	null	0.899902	140	7.429688	65	10	220	null	3	adl>=4 (>=5 if sur)	3
5,090	77.57397	0	female	0	13	674	ARF/MOSF w/Sepsis	ARF/MOSF	1	7	under $11k	0	53,539	30,638.8281	34,531	24.5	white	29.597656	37	0.62793	0.524902	2	1	0	no	0.95	0.94	no dnr	13	105	7.899414	80	20	36.79688	null	null	0.199982	0.599976	142	null	101	11	null	1	0	adl>=4 (>=5 if sur)	0
5,091	70.34399	1	male	0	5	128	ARF/MOSF w/Sepsis	ARF/MOSF	3	5	under $11k	37	10,496	6,644.6328	6,839	18	black	19.898438	36	0.747925	0.668945	1	1	1	no	null	null	no dnr	5	96	10.898438	76	18	36.79688	428.5625	3.699707	0.799927	0.899902	140	7.459961	91	8	null	null	null	adl>=4 (>=5 if sur)	5.283203
5,092	59.37	1	female	1	17	17	Coma	Coma	0	null	null	89	58,477	35,668.375	32,849	35.666657	black	21.398438	25	0.393982	0.319946	1	0	0	no	0.2	0.2	dnr after sadm	17	105	9.398438	105	33	36.29688	175	null	null	1.199951	132	7.439453	251	13	3,130	null	null	<2 mo. follow-up	2.172363
5,093	54.94897	0	female	0	46	672	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	under $11k	0	174,126	null	null	25.75	black	18.199219	10	0.853882	0.803955	26	0	1	no	0.9	0.5	no dnr	46	68	20.898438	125	12	37.39844	184	2.099609	0.199982	0.699951	142	7.389648	89	17	795	null	1	adl>=4 (>=5 if sur)	1
5,094	68.99896	1	male	0	7	134	CHF	COPD/CHF/Cirrhosis	3	12	null	0	19,868	11,311.4609	10,106	20	white	18.796875	18	0.862915	0.773926	1	0	0	no	0.95	0.92	no dnr	7	70	11.5	85	20	36	247.59375	4.099609	1.699951	1.699951	138	7.509766	97	25	1,810	null	0	no(M2 and SIP pres)	0
5,095	71.96399	1	female	1	31	31	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	256,844	137,596.625	120,536	44.25	white	33.796875	53	0.469971	0.350952	16	0	0	no	null	null	dnr after sadm	28	113	11.798828	55	30	38.5	353.3125	null	null	0.599976	136	7.449219	158	11	2,670	null	null	<2 mo. follow-up	2.034668
5,096	47.35098	1	male	0	5	339	Lung Cancer	Cancer	1	12	null	0	3,470	2,491.9434	2,469	4	white	19.898438	13	0.690918	0.40094	1	0	0	metastatic	0.3	0.1	no dnr	5	74	11.398438	126	24	38.39844	304	null	0.799927	0.899902	128	7.429688	80	26	825	1	2	no(M2 and SIP pres)	2
5,097	69.92499	0	female	0	8	671	COPD	COPD/CHF/Cirrhosis	1	18	>$50k	0	8,151	5,344.1797	6,379	5.5	white	15.5	23	0.886963	0.810913	1	0	0	no	0.9	0.8	no dnr	8	57	4.099609	115	40	35.59375	192.71875	2.099609	0.799927	1.299805	148	7.479492	82	21	4,140	0	0	no(M2 and SIP pres)	0
5,098	33.577	0	female	0	10	671	MOSF w/Malig	ARF/MOSF	1	13	$25-$50k	0	50,575	29,621.375	30,226	33.5	black	36.898438	60	0.326965	0.211975	8	0	0	yes	0.75	0.5	no dnr	10	130	8.898438	64	22	35.59375	null	3.099609	0.799927	1.599854	134	null	129	34	null	null	0	no(M2 and SIP pres)	0
5,099	27.392	0	female	0	24	671	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	26	54,847	34,702.4688	33,386	28	white	27.796875	39	0.815918	0.753906	1	0	0	no	0.8	0.8	no dnr	24	70	7.699219	80	28	36.69531	154	1.799805	1.099854	2	138	7.399414	303	51	2,825	0	0	no(M2 and SIP pres)	0
5,100	55.715	1	female	0	12	211	Lung Cancer	Cancer	1	12	null	0	13,445	9,268.0547	10,704	12	white	18.597656	32	0.698975	0.411987	1	0	0	metastatic	0.8	0.6	no dnr	12	72	17.199219	115	28	36.59375	217.125	null	0.699951	0.899902	129	7.489258	102	8	2,750	null	1	no(M2 and SIP pres)	1

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.